Insider Selling: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Major Shareholder Sells 6,422 Shares of Stock
MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Ventures V. L.P. 5Am sold 6,422 shares of Entrada Therapeutics stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of $6.81, for a total value of $43,733.82. Following the sale, the insider owned 1,106,670 shares in the company, valued at $7,536,422.70. This represents a 0.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.
NASDAQ:TRDA